Machine-learning driven findings uncover new cellular players in tumor microenvironment

(CytoReason) New findings presented today by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients -- those who have already failed to respond to ipilimumab (anti-CTLA4) immunotherapy. Once validated, the findings could point the way to improved strategies for the staging and ordering of key immunotherapies in refractory melanoma.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news